Lisata Therapeutics Inc. (LSTA NASDAQ) stock market data APIs
$1.6306
0.08(4.9%)
as of September 11, 2026
Try our APIs with
free plan!
Lisata Therapeutics Inc. Financial Data Overview
Price chart is built with
Anychart
Lisata Therapeutics, Inc., a clinical-stage pharmaceutical company, engages in the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product is certepetide, which is in Phase 2 clinical studies for the treatment of solid tumors, such as metastatic pancreatic ductal adenocarcinoma, cholangiocarcinoma, appendiceal cancer, and colon cancer and glioblastoma multiforme in combination with range of anti-cancer regimens. Lisata Therapeutics, Inc. was formerly known as Caladrius Biosciences, Inc. and changed its name to Lisata Therapeutics, Inc. in September 2022. The company was incorporated in 1980 and is headquartered in Basking Ridge, New Jersey. As of July 21, 2026, Lisata Therapeutics, Inc. operates as a subsidiary of Kuva Labs, Inc.
Prev. Close
1.6306
Open
1.714
High
1.733
Low
1.5826
52 wk Range
0.9875-5.07
Market Cap
14 688 K
Shares Outstanding
9 011 K
Revenue
100 K
EPS
-0.54
Beta
0.945
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Lisata Therapeutics Inc. data using free add-ons & libraries
Get Lisata Therapeutics Inc. Fundamental Data
Lisata Therapeutics Inc. Fundamental data includes:
- Net Revenue: 100 K
- EBITDA: -16 362 000
- Earnings Per Share: -1
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
Get Lisata Therapeutics Inc. Earnings data
Corporate Events Calendar & News package for
$
19.99
/mo.
What’s included:
- Latest Release: 2026-08-20
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Lisata Therapeutics Inc. News
New
Lisata Therapeutics moves forward with legal action following Kuva merger termination
Lisata Therapeutics moves forward with legal action following Kuva merger termination Proactive uses images sourced from Shutterstock Lisata Therapeutics Inc (NASDAQ:LSTA, FRA:8NE) said on Tuesday it...
Lisata Therapeutics Provides Update Following Termination of Merger Agreement
Lisata has filed suit against Kuva Labs Inc. and its subsidiary seeking, among other things, damages for the benefit of its stockholders Lisata’s Board of Directors and management continues to eval...
Lisata Therapeutics plunges after sale to Kuva Labs terminated
[Portrait of confident scientists in laboratory] Morsa Images/DigitalVision via Getty Images * Lisata Therapeutics (LSTA [https://seekingalpha.com/symbol/LSTA]) sank 16% after its planned sale to K...
Lisata Therapeutics agrees to Kuva Labs buyout at $4 per share
Lisata Therapeutics Inc (NASDAQ:LSTA, FRA:8NE) has agreed to be acquired by privately held Kuva Labs Inc. for $4 per share in cash, plus a contingent value right worth up to an additional $3.00 per sh...
Get Lisata Therapeutics Inc. fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
Best Offer
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
